Natrix Separations
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $1.7m | Series A | |
$19.0m | Series B | ||
N/A | $8.0m | Debt | |
N/A | Acquisition | ||
Total Funding | €18.8m |
Recent News about Natrix Separations
EditNatrix Separations specializes in providing advanced chromatography and filtration solutions tailored for the biopharmaceutical and life sciences sectors. The company focuses on delivering high-performance products that enhance the efficiency and effectiveness of laboratory workflows, ensuring regulatory compliance and optimizing quality control processes. Natrix Separations serves a diverse range of clients, including pharmaceutical companies, research institutions, and diagnostic labs, operating within the global life sciences market. The business model revolves around the development, manufacturing, and sale of proprietary chromatography and filtration technologies, generating revenue through direct sales, eProcurement platforms, and specialized customer support services. The company also offers a suite of digital tools and applications designed to support laboratory operations and regulatory compliance.
Keywords: chromatography, filtration, biopharmaceutical, life sciences, regulatory compliance, quality control, laboratory workflows, digital tools, eProcurement, proprietary technologies.